All Relations between dopaminergic and neurotransmitter

Publication Sentence Publish Date Extraction Date Species
M Ansseau, R Von Frenckell, J L Cerfontaine, P Papart, G Franck, M Timsit-Berthier, V Geenen, J J Legro. Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. The British journal of psychiatry : the journal of mental science. vol 153. 1989-04-05. PMID:3224252. these results support the hypothesis of both noradrenergic and dopaminergic neurotransmitter disturbances in major depression, with individual variability with regard to those biochemical anomalies. 1989-04-05 2023-08-11 Not clear
M B Spina, G Cohe. Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. vol 86. issue 4. 1989-03-27. PMID:2919185. parkinson disease is characterized by a major loss (approximately 80% or more) of dopaminergic nigrostriatal neurons and by an increased turnover of neurotransmitter by surviving neurons of the nigrostriatal tract. 1989-03-27 2023-08-11 mouse
T J Mahali. Direct demonstration of interactions between substance P immunoreactive terminals and tyrosine hydroxylase immunoreactive neurons in the substantia nigra of the rat: an ultrastructural study. Synapse (New York, N.Y.). vol 2. issue 5. 1988-12-21. PMID:2460962. these findings support the idea that substance p is a major neurotransmitter in the striatonigral loop, and suggest that striatal substance p neurons act directly upon nigral dopaminergic cells. 1988-12-21 2023-08-11 rat
G Debonnel, C de Montign. Increased neuronal responsiveness to cholecystokinin and dopamine induced by lesioning mesolimbic dopaminergic neurons: an electrophysiological study in the rat. Synapse (New York, N.Y.). vol 2. issue 5. 1988-12-21. PMID:2903570. however, in the dorsal hippocampus, dopaminergic projections from the vta do not contain cck, the latter neurotransmitter being mainly localized in intrinsic hippocampal neurons. 1988-12-21 2023-08-11 rat
M S Fiandaca, J H Kordower, J T Hansen, S S Jiao, D M Gas. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration. Experimental neurology. vol 102. issue 1. 1988-12-07. PMID:2903068. there are two major hypotheses proposed to explain why adrenal medullary grafts may promote functional recovery in human parkinsonism: (1) replacement of lost striatal neurotransmitter (dopamine) by the viable grafted tissue, or (2) induction of recovery of remaining host dopaminergic systems by the implantation procedure. 1988-12-07 2023-08-11 human
D M Vaughn, E Coleman, S T Simpson, C Satjawatcharaphon. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid. American journal of veterinary research. vol 49. issue 8. 1988-11-15. PMID:2459997. the neurotransmitter index, hva/5-hiaa, was found to be more indicative of the dopaminergic metabolite hva than the acid metabolite of serotonin, 5-hiaa (correlation coefficient with hva = 0.5529 vs a correlation coefficient with 5-hiaa = -0.4462). 1988-11-15 2023-08-11 Not clear
D Quartermain, M E Judge, P Le. Attenuation of forgetting by pharmacological stimulation of aminergic neurotransmitter systems. Pharmacology, biochemistry, and behavior. vol 30. issue 1. 1988-10-31. PMID:2902645. thirty min prior to testing animals were injected with either saline or different doses of drugs which activate the noradrenergic (phenylephrine, salbutamol, clonidine) dopaminergic (l-dopa(sinemet) transdihydrolisuride, apomorphine) and serotonergic (fluoxetine, 5-methoxy dmt) neurotransmitter systems. 1988-10-31 2023-08-11 mouse
D G Lichter, A J Corbett, G M Fitzgibbon, O R Davidson, J K Hope, G V Goddard, K J Sharples, M Polloc. Cognitive and motor dysfunction in Parkinson's disease. Clinical, performance, and computed tomographic correlations. Archives of neurology. vol 45. issue 8. 1988-08-25. PMID:3293555. further prospective clinicopathologic studies will be required to clarify the relative contribution of the primary dopaminergic dysfunction, age-related changes, alzheimer-type pathologic condition, and other coexisting neurotransmitter deficits to the dementia seen in pd. 1988-08-25 2023-08-11 Not clear
G J Nishioka, M T Montgomer. Masticatory muscle hyperactivity in temporomandibular disorders: is it an extrapyramidally expressed disorder? Journal of the American Dental Association (1939). vol 116. issue 4. 1988-07-19. PMID:2897984. experimental evidence suggests a neurotransmitter imbalance in the basal ganglia, involving dopaminergic preponderance, or cholinergic and gaba-nergic hypofunction as the underlying cause. 1988-07-19 2023-08-11 Not clear
A H Lauber, R E Whale. Muscarinic cholinergic modulation of hypothalamic estrogen binding sites. Brain research. vol 443. issue 1-2. 1988-05-31. PMID:2896055. studies from other laboratories have demonstrated that agents which interact with the dopaminergic and noradrenergic neurotransmitter systems alter the concentrations of cytosolic hypothalamic estrogen receptors. 1988-05-31 2023-08-11 rat
V K Shukla, S K Garg, S K Kulkarn. GABAergic, dopaminergic and cholinergic interaction in tremorine-induced tremors in mice. Methods and findings in experimental and clinical pharmacology. vol 10. issue 1. 1988-05-16. PMID:2895827. the modification of the protective effect of anticholinergic and dopaminergic agents by gabaergic agents has been explained on the basis of neurotransmitter interaction. 1988-05-16 2023-08-11 mouse
R Dal Toso, O Giorgi, C Soranzo, G Kirschner, G Ferrari, M Favaron, D Benvegnù, D Presti, S Vicini, G Toffan. Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: I. Effects of cell density and of an adult mammalian striatal-derived neuronotrophic factor (SDNF). The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 8. issue 3. 1988-04-14. PMID:3346717. in particular the development, i.e., neurotransmitter uptake characteristics, and survival of dopaminergic and gabaergic neurons in fetal mouse (e13)-dissociated mesencephalic cells cultured in serum-free, hormone-supplemented medium have been assessed as a function of culture time and cell density. 1988-04-14 2023-08-11 mouse
R Dal Toso, O Giorgi, C Soranzo, G Kirschner, G Ferrari, M Favaron, D Benvegnù, D Presti, S Vicini, G Toffan. Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: I. Effects of cell density and of an adult mammalian striatal-derived neuronotrophic factor (SDNF). The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 8. issue 3. 1988-04-14. PMID:3346717. in particular, bovine striatal extracts contain activity capable of increasing high-affinity neurotransmitter uptake parameters and cell survival of at least the dopaminergic and gabaergic neurons present in the culture system. 1988-04-14 2023-08-11 mouse
A Leon, R Dal Toso, D Presti, D Benvegnù, L Facci, G Kirschner, G Tettamanti, G Toffan. Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: II. Modulatory effects of gangliosides. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 8. issue 3. 1988-04-14. PMID:3346718. this paper analyzes the effects of exogenously supplied gm1 on the development, i.e., specific neurotransmitter uptake capability and survival, of the dopaminergic neurons present in fetal mouse-dissociated mesencephalic cells. 1988-04-14 2023-08-11 Not clear
A W Rutgers, J P Lakke, A M Paans, W Vaalburg, J Kor. Tracing of dopamine receptors in hemiparkinsonism with positron emission tomography (PET). Journal of the neurological sciences. vol 80. issue 2-3. 1987-12-22. PMID:3500276. since the postsynaptic receptor changes in hemiparkinson patients appear not to be uniform, these results suggest that the clinical asymmetry is not only caused by a dysfunction of nigral dopaminergic cells, but by pathology in other cells and probably in other neurotransmitter systems as well. 1987-12-22 2023-08-11 Not clear
U di Porzio, G Rougon, E A Novotny, J L Barke. Dopaminergic neurons from embryonic mouse mesencephalon are enriched in culture through immunoreaction with monoclonal antibody to neural specific protein 4 and flow cytometry. Proceedings of the National Academy of Sciences of the United States of America. vol 84. issue 20. 1987-11-25. PMID:2890165. dopaminergic neurons represent a rare neurotransmitter phenotype within the mammalian central nervous system. 1987-11-25 2023-08-11 mouse
A Morales, M Condra, J A Owen, D H Surridge, J Fenemore, C Harri. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. The Journal of urology. vol 137. issue 6. 1987-06-29. PMID:3295302. adrenoceptors are involved in the erectile process, although other neurotransmitter systems also are putative modulators of penile erection, including cholinergic, dopaminergic and vasoactive intestinal polypeptide pathways. 1987-06-29 2023-08-11 Not clear
G S Roth, J M Henry, J A Josep. The striatal dopaminergic system as a model for modulation of altered neurotransmitter action during aging: effects of dietary and neuroendocrine manipulations. Progress in brain research. vol 70. 1987-06-08. PMID:3554360. the striatal dopaminergic system as a model for modulation of altered neurotransmitter action during aging: effects of dietary and neuroendocrine manipulations. 1987-06-08 2023-08-11 Not clear
D M Mann, P O Yates, B Marcyniu. Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age. Journal of neurology, neurosurgery, and psychiatry. vol 50. issue 3. 1987-05-18. PMID:2951499. dopaminergic neurotransmitter systems in alzheimer's disease and in down's syndrome at middle age. 1987-05-18 2023-08-11 Not clear
K A Gregerson, M Selmanof. Rapid release of [3H]dopamine from median eminence and striatal synaptosomes. Journal of neurochemistry. vol 48. issue 4. 1987-04-22. PMID:3819726. these data are consistent with differences between these two types of dopaminergic terminals with respect to packaging and/or distribution of the accumulated neurotransmitter in intraneuronal pools, as well as marked differences in the apparent kinetics of da release. 1987-04-22 2023-08-11 rat